Net Asset Value(s)

Baronsmead VCT 2 PLC
08 December 2006

To:       RNS



Date:     8 December 2006



Company:  Baronsmead VCT 2 plc



Subject:  GlaxoSmithKline to acquire Domantis for $454m


The Board of Baronsmead VCT 2 plc is pleased to report that GlaxoSmithKline plc
(GSK) today announced that it has entered into an agreement to acquire Domantis
Ltd for US$454 million in cash.


Domantis, a privately owned company was started in 2000 by the Medical Research
Council and MVM Ltd.  Baronsmead VCT 2 plc initially invested in the company in
April 2004 and now has a total holding of £400,303.  The announcement made today
by the company represents an uplift of £954,180, in the net asset value
attributable to the ordinary shares of Baronsmead VCT 2 plc which equates to
2.37p per ordinary share.



For further information contact:



David Thorp, ISIS EP LLP:                            0207 506 1609

Rhonda Nicoll, F&C Asset Management plc:             0131 718 1074




                      This information is provided by RNS
            The company news service from the London Stock Exchange